Japanese patent for HIV immuno-monitoring:
This article was originally published in Clinica
Executive Summary
Cel-Sci has received a Japanese patent for an immunodiagnostic technique that monitors HIV progression. The assay, which is under development at the University of Maryland, measures the levels of antibodies that bind to HIV-1 p17 peptides in serum. Cel-Sci plans to develop a test that is cheaper than genetic amplification tests.